PMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ProMIS Neurosciences Inc (PMN) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive financial performance, absence of significant trading trends, and no strong technical or proprietary trading signals suggest a 'hold' recommendation for now.
The MACD is positive and expanding, indicating a slight bullish momentum. However, the RSI is neutral at 31.802, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is currently trading near its support level (S1: 10.774), but there is no clear indication of a strong upward trend.
NULL identified. No recent news or events to act as a catalyst.
The company has negative financial performance with significant losses in net income and EPS, despite the YoY improvement. No insider or hedge fund activity indicates a lack of confidence in the stock.
In Q4 2025, the company reported no revenue growth (0% YoY). Net income improved YoY but remains significantly negative (-$10,674,088). EPS also improved but is still negative (-4.14). Gross margin is 0%, indicating no profitability.
No analyst rating or price target changes available for review.
